Your browser doesn't support javascript.
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.
Allocca, Mariangela; Fiorino, Gionata; Zallot, Camille; Furfaro, Federica; Gilardi, Daniela; Radice, Simona; Danese, Silvio; Peyrin-Biroulet, Laurent.
  • Allocca M; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy. Electronic address: mariangela.allocca@humanitas.it.
  • Fiorino G; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.
  • Zallot C; Department of Gastroenterology, Inserm U1256 Nutrition - génétique et exposition aux risques environnementaux, Nancy University Hospital, Lorraine University, Vandoeuvre-les-Nancy, France.
  • Furfaro F; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.
  • Gilardi D; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.
  • Radice S; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.
  • Danese S; Humanitas Clinical and Research Center, Istituto di ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.
  • Peyrin-Biroulet L; Department of Gastroenterology, Inserm U1256 Nutrition - génétique et exposition aux risques environnementaux, Nancy University Hospital, Lorraine University, Vandoeuvre-les-Nancy, France.
Clin Gastroenterol Hepatol ; 18(9): 2134-2135, 2020 08.
Article in English | MEDLINE | ID: covidwho-154981
ABSTRACT
The first cases of COVID-19 infection were reported in December, 2019, in Wuhan, China. Italy (in particular Lombardy) and France (in particular Northeast) have been gravely hit. Both physicians and inflammatory bowel disease (IBD) patients are deeply concerned that immunosuppressants or biologics may increase the risk of COVID-19 infection. IOIBD has put in place an international registry, SECURE-IBD, for tracking all the cases with IBDs infected by COVID-19 (SECURE-IBD registry http//www.covidibd.org). It will describe the outcomes of infected patients and the association between IBD-related medications and these outcomes.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Inflammatory Bowel Diseases / Coronavirus Infections / Betacoronavirus Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Clin Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Inflammatory Bowel Diseases / Coronavirus Infections / Betacoronavirus Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Clin Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2020 Document Type: Article